| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.008 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |